| 05/05/2026 2:02 PM | Citius Oncology (1851484) Filer | Form 424B3 | |
| 04/28/2026 4:00 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 3:30 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/10/2026 8:11 AM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 8:25 AM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 11:15 PM | Citius Oncology (1851484) Filer | Form EFFECT | |
| 02/17/2026 8:52 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Citius Oncology (1851484) Subject | Form SCHEDULE 13G/A | |
| 02/13/2026 7:30 AM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/13/2026 7:00 AM | Citius Oncology (1851484) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 01/20/2026 3:30 PM | Citius Oncology (1851484) Filer | Form PRE 14C | |
| 01/12/2026 11:15 PM | Citius Oncology (1851484) Filer | Form EFFECT | |
Get the Latest News and Ratings for CTOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter.
|
| 12/23/2025 3:50 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/23/2025 3:20 PM | Citius Oncology (1851484) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:10 PM | Citius Oncology (1851484) Issuer Holuka Eugene Myron (1678292) Reporting | Form 4/A | |
| 12/22/2025 3:10 PM | Citius Oncology (1851484) Issuer Dutia Suren G (1514063) Reporting | Form 4/A | |
| 12/22/2025 3:10 PM | Citius Oncology (1851484) Issuer Mayersohn Joel David (1588395) Reporting | Form 4/A | |
| 12/22/2025 3:10 PM | Citius Oncology (1851484) Issuer MCGRATH DENNIS M (1269340) Reporting | Form 4/A | |
| 12/22/2025 3:10 PM | Citius Oncology (1851484) Issuer Smith Robert Joseph (2008764) Reporting | Form 4/A | |
| 12/22/2025 3:10 PM | Citius Oncology (1851484) Issuer Mazur Leonard L (1463414) Reporting | Form 4/A | |
| 12/22/2025 3:10 PM | Bartushak Jaime (1725077) Reporting Citius Oncology (1851484) Issuer | Form 4/A | |
| 12/22/2025 3:10 PM | Citius Oncology (1851484) Issuer Czuczman Myron (1817716) Reporting | Form 4/A | |
| 12/22/2025 3:10 PM | Citius Oncology (1851484) Issuer HOLUBIAK MYRON Z (1199080) Reporting | Form 4/A | |
| 12/22/2025 3:10 PM | Citius Oncology (1851484) Issuer Webb Carol (1671111) Reporting | Form 4/A | |
| 12/17/2025 3:10 PM | Citius Oncology (1851484) Subject Citius Pharmaceuticals, Inc. (1506251) Filed by | Form SCHEDULE 13D/A | |
| 12/10/2025 4:29 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/01/2025 4:12 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 5:41 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Citius Oncology (1851484) Subject | Form SCHEDULE 13G | |
| 10/27/2025 3:30 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/23/2025 4:09 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/26/2025 3:30 PM | Citius Oncology (1851484) Filer | Form DEF 14A | |
| 09/23/2025 3:10 PM | Citius Oncology (1851484) Issuer Holuka Eugene Myron (1678292) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:10 PM | Citius Oncology (1851484) Issuer Dutia Suren G (1514063) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:10 PM | Citius Oncology (1851484) Issuer Mayersohn Joel David (1588395) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:10 PM | Bartushak Jaime (1725077) Reporting Citius Oncology (1851484) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:10 PM | Citius Oncology (1851484) Issuer MCGRATH DENNIS M (1269340) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:10 PM | Citius Oncology (1851484) Issuer Czuczman Myron (1817716) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:10 PM | Citius Oncology (1851484) Issuer Webb Carol (1671111) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:10 PM | Citius Oncology (1851484) Issuer Mazur Leonard L (1463414) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:10 PM | Citius Oncology (1851484) Issuer Smith Robert Joseph (2008764) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 3:10 PM | Citius Oncology (1851484) Issuer HOLUBIAK MYRON Z (1199080) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/19/2025 4:00 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
| 09/19/2025 4:12 PM | Citius Oncology (1851484) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 09/12/2025 3:15 PM | Citius Oncology (1851484) Subject Citius Pharmaceuticals, Inc. (1506251) Filed by | Form SCHEDULE 13D/A | |
| 09/10/2025 4:00 PM | Citius Oncology (1851484) Filer | Form 424B3 | |
| 09/10/2025 3:45 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/10/2025 7:30 AM | Citius Oncology (1851484) Filer | Form 424B5 | |
| 09/04/2025 11:15 PM | Citius Oncology (1851484) Filer | Form EFFECT | |
| 09/02/2025 7:00 AM | Citius Oncology (1851484) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 08/12/2025 3:45 PM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2025 3:30 PM | Citius Oncology (1851484) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/18/2025 7:01 AM | Citius Oncology (1851484) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/16/2025 8:21 PM | Citius Oncology (1851484) Filer | Form 424B4 | |
| 07/16/2025 11:15 PM | Citius Oncology (1851484) Filer | Form EFFECT | |
| 07/14/2025 4:22 PM | Citius Oncology (1851484) Filer | Form S-1/A | |
| 07/14/2025 7:31 AM | Citius Oncology (1851484) Filer | Form S-1 Registration statement under Securities Act of 1933 | |